M&A Deal Summary |
|
|---|---|
| Date | 2020-12-21 |
| Target | Nualtra |
| Sector | Life Science |
| Buyer(s) | Ajinomoto Cambrooke |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2000 |
| Sector | Life Science |
Ajinomoto Cambrooke, Inc. is a therapeutic nutrition company and global provider of medical nutrition products for patients with serious, chronic, unmet medical needs. The company works with physicians and researchers from around the world to develop, test and commercialize products that are today focused on inborn errors of metabolism and intractable epilepsy.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: United Kingdom M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |